Domov › Nemalobunkový karcinóm pľúc › Virginia › Arlington
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Arlington, VA
104 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Arlington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11 míľ odtiaľ
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Prebieha náborFáza 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11 míľ odtiaľ
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Prebieha náborFáza 2/3
- Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Prebieha náborFáza 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11 míľ odtiaľ
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Prebieha náborFáza 1
- Site 04, Fairfax · 11 míľ odtiaľ
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Prebieha náborFáza 1
- ALX Center 2, Fairfax · 11 míľ odtiaľ
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, Fairfax · 11 míľ odtiaľ
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 1
- Virginia Cancer Specialists PC, Fairfax · 11 míľ odtiaľ
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, Fairfax · 11 míľ odtiaľ
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Prebieha náborFáza 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Prebieha náborFáza 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 míľ odtiaľ
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Prebieha náborFáza 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 míľ odtiaľ
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 3
- Research Site, Fairfax · 11 míľ odtiaľ
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Prebieha náborFáza 3
- Clinical Study Site, Fairfax · 11 míľ odtiaľ
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Prebieha náborFáza 3
- Virginia Cancer Specialists, Arlington
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Prebieha náborFáza 3
- Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT - Virginia, Fairfax · 11 míľ odtiaľ
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Prebieha náborFáza 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 míľ odtiaľ
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Prebieha náborFáza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Next Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · 11 míľ odtiaľ
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Prebieha náborFáza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- USO - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Prebieha náborFáza 3
- Research Site, Fairfax · 11 míľ odtiaľ
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Prebieha náborFáza 1
- Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Research Site, Fairfax · 11 míľ odtiaľ
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Institute, Falls Church · 4 míľ odtiaľ
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site, Fairfax · 11 míľ odtiaľ
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Prebieha náborFáza 3
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
A Study of DM005 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Clinical Trial Site, Fairfax · 11 míľ odtiaľ
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Next Virginia, Fairfax · 11 míľ odtiaľ
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Prebieha náborFáza 1/2
- Research Site, Fairfax · 11 míľ odtiaľ
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Research Site, Fairfax · 11 míľ odtiaľ
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study of LY4175408 in Participants With Advanced Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Prebieha náborFáza 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 míľ odtiaľ
Study of XB010 in Subjects With Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer, Fairfax · 11 míľ odtiaľ
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Prebieha náborFáza 1
- NEXT Texas LLC - Virginia, Fairfax · 11 míľ odtiaľ
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Research Site, Fairfax · 11 míľ odtiaľ
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site, Fairfax · 11 míľ odtiaľ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Prebieha náborFáza 1/2
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Next Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Research Site, Fairfax · 11 míľ odtiaľ
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Prebieha náborFáza 2
- Inova Fairfax Hospital, Fairfax · 11 míľ odtiaľ
A 2-part Phase 1/2 Open-label Trial on ODM-212
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Prebieha náborFáza 1
- Research Site, Fairfax · 11 míľ odtiaľ
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Prebieha náborFáza 1/2
- NEXT, Virginia, Fairfax · 11 míľ odtiaľ
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Prebieha náborFáza 1
- Dren Investigational Site, Fairfax · 11 míľ odtiaľ
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site 102, Fairfax · 11 míľ odtiaľ
- Research Site 112, Fairfax · 11 míľ odtiaľ
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
- Seattle, WA53 štúdií
Iné štúdie v Arlington
- Metastatická rakovina53 štúdií
- Kolorektálny karcinóm52 štúdií
- Rakovina (všetky typy)48 štúdií
- Rakovina prsníka47 štúdií
- Rakovina vaječníkov46 štúdií
- Rakovina pľúc41 štúdií
- Rakovina endometria39 štúdií
- Rakovina pankreasu33 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku26 štúdií
- Malobuněčný rakovina plic23 štúdií
- Rakovina žalúdka20 štúdií
- Trojnásobne negatívny karcinóm prsníka20 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.